Alnylam Pharmaceuticals, Inc. vs. Silence Therapeutics GMBH
Explore the PTAB proceeding PGR2018-00088 filed by Alnylam Pharmaceuticals, Inc. on 2018-07-17. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
PGR2018-00088
Filing Date
2018-07-17
Accorded Filing Date
2018-07-17
Institution Decision Date
—
Last Modified Date
2022-10-07
Proceeding Type
PGR
Termination Date
2018-12-20
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Alnylam Pharmaceuticals, Inc.
Represented By
Scott ReedPatent Owner / Respondent
Silence Therapeutics GMBH
Represented By
Matthew I. KreegerPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 38651 | Michael Ward | +1 415-268-6237 |
| 39933 | Robert Cerpa | +1 650-813-5715 |
| 40130 | Catherine Polizzi | +1 650-813-5651 |
| 45640 | Jonathan Bockman | +1 202-791-8570 |
| 46813 | Parisa Jorjani | +1 415-268-7000 |
| 48231 | Mehran Arjomand | +1 213-892-5630 |
| 50713 | Patricia Tsao | +1 415-268-6642 |
| 51934 | Christine Lekutis | +1 415-268-7060 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.